Compounds > 14,15-epoxy-5,8,11-eicosatrienoic acid
Page last updated: 2024-10-21

14,15-epoxy-5,8,11-eicosatrienoic acid and Cardiomyopathies

14,15-epoxy-5,8,11-eicosatrienoic acid has been researched along with Cardiomyopathies in 1 studies

14,15-epoxy-5,8,11-eicosatrienoic acid: RN given refers to cpd without isomeric designation

Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Alaeddine, LM1
Harb, F1
Hamza, M1
Dia, B1
Mogharbil, N1
Azar, NS1
Noureldein, MH1
El Khoury, M1
Sabra, R1
Eid, AA1

Other Studies

1 other study available for 14,15-epoxy-5,8,11-eicosatrienoic acid and Cardiomyopathies

ArticleYear
Pharmacological regulation of cytochrome P450 metabolites of arachidonic acid attenuates cardiac injury in diabetic rats.
    Translational research : the journal of laboratory and clinical medicine, 2021, Volume: 235

    Topics: 8,11,14-Eicosatrienoic Acid; Animals; Arachidonic Acid; Cardiomyopathies; Cytochrome P-450 Enzyme Sy

2021